{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:09:12Z","timestamp":1740136152035,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32CA009142-40"],"award-info":[{"award-number":["5T32CA009142-40"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.brachy.2023.12.007","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T20:29:29Z","timestamp":1709756969000},"page":"266-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers"],"prefix":"10.1016","volume":"23","author":[{"given":"Tiffany S.","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-6817","authenticated-orcid":false,"given":"Alex","family":"Francoeur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Manrriquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puja","family":"Venkat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Douek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simin","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-1676","authenticated-orcid":false,"given":"Steven S.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanaz","family":"Memarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2023.12.007_bib0001","unstructured":"Noone AM, Howlader N, Krapcho M, et al. SEER cancer statistics review, 1975-2015, National Cancer Institute. Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2015\/, based on November 2017 SEER data submission, posted to the SEER web site, April 2018."},{"key":"10.1016\/j.brachy.2023.12.007_bib0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.03.004","article-title":"Ovarian cancer","volume":"60","author":"Colombo","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0003","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2023.12.007_bib0004","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1634\/theoncologist.2019-0309","article-title":"Enter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study): a collaboration of MITO, AIRO GYN, and MaNGO groups","volume":"25","author":"Macchia","year":"2020","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.brachy.2023.12.007_bib0005","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jvir.2021.01.270","article-title":"Image-guided percutaneous thermal ablation of oligometastatic ovarian and non-ovarian gynecologic tumors","volume":"32","author":"Yuan","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0360-3016(91)90007-Q","article-title":"Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: A final report of the 1973 and 1978 patterns of care studies","volume":"20","author":"Lanciano","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0007","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0360-3016(98)00482-9","article-title":"Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy","volume":"43","author":"Logsdon","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0008","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0009","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ygyno.2014.08.027","article-title":"Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy","volume":"135","author":"Rijkmans","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.brachy.2018.11.009","article-title":"Brachytherapy: a critical component of primary radiation therapy for cervical cancer: from the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS)","volume":"18","author":"Holschneider","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.12.007_bib0011","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.brachy.2014.07.002","article-title":"Image-based three-dimensional conformal brachytherapy for medically inoperable endometrial carcinoma","volume":"13","author":"Gill","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.12.007_bib0012","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2018.08.028","article-title":"Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology","volume":"151","author":"Shinde","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0013","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ijrobp.2015.06.013","article-title":"Brachytherapy is associated with improved survival in inoperable stage I endometrial adenocarcinoma: a population-based analysis","volume":"93","author":"Acharya","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0014","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2016.12.035","article-title":"Brachytherapy improves survival in stage III endometrial cancer with cervical involvement","volume":"97","author":"Bingham","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0015","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/cncr.30228","article-title":"Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A National Cancer Data Base study","volume":"122","author":"Rydzewski","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2023.12.007_bib0016","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ygyno.2016.03.011","article-title":"Brachytherapy improves survival in primary vaginal cancer","volume":"141","author":"Orton","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0360-3016(94)90148-1","article-title":"The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone","volume":"28","author":"Eifel","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.semradonc.2019.08.001","article-title":"Interstitial high-dose-rate gynecologic brachytherapy: clinical workflow experience from three academic institutions","volume":"30","author":"Prisciandaro","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0019","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1007\/s00330-006-0241-2","article-title":"CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies","volume":"16","author":"Wieners","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0020","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5114\/jcb.2019.88141","article-title":"Efficacy and safety of percutaneous computed tomography-guided high-dose-rate interstitial brachytherapy in treatment of oligometastatic lymph node metastases of retroperitoneal space","volume":"11","author":"Heinze","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.12.007_bib0021","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1378\/chest.127.6.2237","article-title":"CT guided interstitial single fraction brachytherapy of lung tumors: phase I results of a novel technique","volume":"127","author":"Ricke","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.brachy.2023.12.007_bib0022","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.RVI.0000141343.43441.06","article-title":"Liver malignancies: CT- guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation","volume":"15","author":"Ricke","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0023","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.ejrad.2013.05.037","article-title":"Computed tomographic guided iodine-125 interstitial implants for malignant thoracic tumors","volume":"82","author":"Huang","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0024","first-page":"2597","article-title":"CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience","volume":"31","author":"Collettini","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2023.12.007_bib0025","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0026","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13014-021-01826-1","article-title":"Outcomes with multi-disciplinary management of central lung tumors with CT-guided percutaneous high dose rate brachyablation","volume":"16","author":"Yoon","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0027","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.brachy.2020.12.008","article-title":"Interstitial brachytherapy for gynecologic malignancies: complications, toxicities, and management","volume":"20","author":"Kamrava","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.12.007_bib0028","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.21037\/gs-20-325","article-title":"Secondary and tertiary ovarian cancer recurrence: what is the best management?","volume":"9","author":"Garzon","year":"2020","journal-title":"Gland Surg"},{"year":"2021","series-title":"Cancer facts & figures 2021","key":"10.1016\/j.brachy.2023.12.007_bib0029"},{"key":"10.1016\/j.brachy.2023.12.007_bib0030","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.brachy.2020.12.011","article-title":"High-dose-rate interstitial brachytherapy for vaginal endometrial cancer recurrence after prior surgery and radiotherapy","volume":"20","author":"Chapman","year":"2021","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.12.007_bib0031","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.brachy.2023.12.007_bib0032","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0033","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0034","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ygyno.2020.10.001","article-title":"Stereotactic body radiation therapy (SBRT) in recurrent, persistent or oligometastatic gynecological cancers","volume":"159","author":"Reshko","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","article-title":"Image-guided stereotactic body radiation therapy in patients with isolated Para-aortic lymph node metastases from uterine cervical and corpus cancer","volume":"74","author":"Choi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.12.007_bib0036","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0037","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-021-01812-7","article-title":"Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma","volume":"16","author":"Walter","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2023.12.007_bib0038","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472124000060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:59:36Z","timestamp":1728910776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472124000060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1538472124000060"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.12.007","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}